Pedro Sánchez‐Rovira - Researcher Profile

Publications

2 shown

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

Ian Smith , Marion Procter , Richard D. Gelber +21 more

2007 The Lancet 1503 citations

Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.

Yuri Agrawal , Aranzazu Fernández-Martínez , Miguel Gil‐Gil +26 more

PURPOSE: For hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer (MBC), first-line cyclin-dependent kinase 4/6 inhib...

2025 UNC Libraries 0 citations

Frequent Co-Authors

Researcher Info

h-index: 1
Publications: 2
Citations: 1,503
Institution: Complejo Hospitalario de Jaén

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-2658-1467

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.